Related Experiment Video

Updated: Jul 3, 2026

ROS Live Cell Imaging During Neuronal Development
09:25

ROS Live Cell Imaging During Neuronal Development

Published on: February 9, 2021

Inhibitory action of NoxA1 on dual oxidase activity in airway cells

Sandrine Pacquelet1, Mandy Lehmann, Sylvia Luxen

  • 1Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California 92037, USA.

The Journal of Biological Chemistry
|July 9, 2008
PubMed

Insights

Reactive oxygen species (ROS) regulation in the lungs is crucial for function. This study reveals a novel inhibitory role for NADPH oxidase (Noxa1) in controlling dual oxidase (Duox)-mediated hydrogen peroxide production in airway epithelium.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Biochemistry

Background:

  • Lung function relies on balancing pro- and antioxidant mechanisms to maintain oxygenation and host defense.
  • Reactive oxygen species (ROS), particularly hydrogen peroxide (H2O2), are tightly regulated in the respiratory tract.
  • The NADPH oxidase dual oxidase (Duox) is implicated as a key source of regulated H2O2 in airway epithelium.

Purpose of the Study:

  • To investigate the expression, function, and regulation of Duox in a differentiated mucociliary airway epithelium model.
  • To elucidate the role of the regulatory protein Noxa1 in Duox-mediated H2O2 production.
  • To explore the mechanism of Duox regulation by calcium flux and Noxa1.

Main Methods:

  • Utilized a fully differentiated, mucociliary airway epithelium model.
  • Reconstituted a functional Duox1-based oxidase in model cell lines for mutational analysis.
  • Performed knockdown of Noxa1 in airway cells.
  • Investigated the impact of calcium flux on Noxa1-Duox interaction.

Main Results:

  • Duox-mediated H2O2 generation was dependent on calcium flux, which facilitated Noxa1 dissociation from Duox.
  • Mutation of a proline-rich domain in Duox C terminus or Noxa1 knockdown increased basal and stimulated H2O2 production.
  • Noxa1 was identified to have a novel inhibitory function in Duox regulation.

Conclusions:

  • Noxa1 acts as an inhibitor of Duox activity, representing a new regulatory paradigm for NADPH oxidases.
  • Calcium signaling promotes Duox activation by relieving Noxa1-induced constraints.
  • Understanding Duox regulation by Noxa1 is critical for respiratory health and disease.

More Related Videos

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models10:42

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models

Published on: October 22, 2012

Novel Whole-tissue Quantitative Assay of Nitric Oxide Levels in Drosophila Neuroinflammatory Response07:49

Novel Whole-tissue Quantitative Assay of Nitric Oxide Levels in Drosophila Neuroinflammatory Response

Published on: December 4, 2013

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...